The panel applied in this study covered a total of five CAH-related genes (CYP21A2, CYP11B1, CYP17A1, HSD3B2, and STAR) and represents a novel molecular screening approach with 100% detection rate and specificity. Here, CYP21A2 is linked to congenital adrenal hyperplasia.